Translational Research
Volume 156, Issue 4 , Pages 242-250 , October 2010

Plasma selenoproteins concentrations in type 2 diabetes mellitus—a pilot study

  • Marco Roman

      Affiliations

    • Department of Environmental Sciences, University of Venice Ca’ Foscari, Venice, Italy
    • ,
  • Annunziata Lapolla

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    • ,
  • Petru Jitaru

      Affiliations

    • Institute for the Dynamics of Environmental Processes (IDPA-CNR), Venice, Italy
    • Institut Polytechnique LaSalle Beauvais, Département des Sciences et Techniques Agro-Industrielles, Beauvais Cedex, France
    • ,
  • Annalisa Sechi

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    • ,
  • Chiara Cosma

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Padova, Italy
    • ,
  • Giulio Cozzi

      Affiliations

    • Department of Environmental Sciences, University of Venice Ca’ Foscari, Venice, Italy
    • Institute for the Dynamics of Environmental Processes (IDPA-CNR), Venice, Italy
    • ,
  • Paolo Cescon

      Affiliations

    • Department of Environmental Sciences, University of Venice Ca’ Foscari, Venice, Italy
    • Institute for the Dynamics of Environmental Processes (IDPA-CNR), Venice, Italy
    • ,
  • Carlo Barbante

      Affiliations

    • Department of Environmental Sciences, University of Venice Ca’ Foscari, Venice, Italy
    • Institute for the Dynamics of Environmental Processes (IDPA-CNR), Venice, Italy
    • Corresponding Author InformationReprint requests: Carlo Barbante, Department of Environmental Sciences, University of Venice Ca Foscari, Dorsoduro 2137, 30123 Venice, Italy

Received 5 March 2010 ,Revised 13 July 2010 ,Accepted 15 July 2010.

References 

  1. Ezaki O. The insulin-like effects of selenate in rat adipocytes. J Biol Chem. 1990;265:1124–1128
  2. McNeill JH, Delgatty HLM, Battell ML. Insuline-like effects of sodium selenate in streptozocin-induced diabetic rats. Diabetes. 1991;40:1675–1678
  3. Stapleton SR. Selenium: an insulin-mimetic. Cell Mol Life Sci. 2000;57:1874–1879
  4. Erbayraktar Z, Yflmaz O, Artmann AET, Cehreli R, Coker C. Effects of selenium supplementation on antioxidant Defense and glucose homeostasis in experimental diabetes mellitus. Biol Trace Elem Res. 2007;118:217–226
  5. Ayaz M, Can B, Ozdemir S, Turan B. Protective effect of selenium treatment on diabetes-induced myocardial structural alterations. Biol Trace Elem Res. 2002;89:215–226
  6. Ayaz M, Ozdemir S, Ugur M, Vassort G, Turan B. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat. Arch Biochem Biophys. 2004;426:83–90
  7. Battell ML, Delgatty HLM, McNeill JH. Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats. Mol Cell Biochem. 1998;179:27–34
  8. Douillet C, Bost M, Accominotti M, BorsonChazot F, Ciavatti M. In vitro and in vivo effects of selenium and selenium with vitamin E on platelet functions in diabetic rats relationship to platelet sorbitol and fatty acid distribution. Biol Trace Elem Res. 1996;55:263–277
  9. Douillet C, Tabib A, Bost M, Accominotti M, BorsonChazot F, Ciavatti M. A Selenium supplement associated or not with vitamin E delays early renal lesions in experimental diabetes in rats. Proc Soc Exp Biol Med. 1996;211:323–331
  10. Zheng HT, Zhou LN, Huang CJ, et al. Selenium inhibits high glucose- and high insulin-induced adhesion molecule expression in vascular endothelial cells. Arch Med Res. 2008;39:373–379
  11. Mueller AS, Pallauf J. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J Nutr Biochem. 2006;17:548–560
  12. Navarro-Alarcon M, de la Serrana HLG, Perez-Valero V, Lopez-Martinez C. Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ. 1999;228:79–85
  13. Kljai K, Runje R. Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res. 2001;83:223–229
  14. Kornhauser C, Garcia-Ramirez JR, Wrobel K, Pérez-Luque E-L, Garay-Sevilla ME, Wrobel K. Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim Care Diabetes. 2008;2:81–85
  15. Whiting PH, Kalansooriya A, Holbrook I, Haddad F, Jennings PE. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci. 2008;65:71–74
  16. Bo S, Lezo A, Menato G, et al. Gestational hyperglycemia, zinc, selenium, and antioxidant vitamins. Nutrition. 2005;21:186–191
  17. Molnar J, Garamvolgyi Z, Herold M, Adanyi N, Somogyi A, Rigo J. Serum selenium concentrations correlate significantly with inflammatory biomarker high-sensitive CRP levels in hungarian gestational diabetic and healthy pregnant women at mid-pregnancy. Biol Trace Elem Res. 2008;121:16–22
  18. Hawkes WC, Alkan Z, Lang K, King JC. Plasma selenium decrease during pregnancy is associated with glucose intolerance. Biol Trace Elem Res. 2004;100:19–29
  19. Kilinc M, Guven MA, Ezer M, Ertas IE, Coskun A. Evaluation of serum selenium levels in Turkish women with gestational diabetes mellitus, glucose intolerants, and normal controls. Biol Trace Elem Res. 2008;123:35–40
  20. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in US adults. Diabetes Care. 2007;30:829–834
  21. Ekmekcioglu C, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl W. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res. 2001;79:205–219
  22. Serdar MA, Bakir F, Hasimi A, et al. Trace and toxic element patterns in nonsmoker patients with noninsulin-dependent diabetes mellitus, impaired glucose tolerance, and fasting glucose. Int J Diabetes Dev Ctries. 2009;29:35–40
  23. Wang WC, Makela AL, Nanto V, Makela P. Serum selenium levels in diabetic children. A followup study during selenium-enriched agricultural fertilization in Finland. Biol Trace Elem Res. 1995;47:355–364
  24. Cser A, Sziklai-Laszlo I, Menzel H, Lombeck I. Selenium status and lipoproteins in healthy and diabetic children. J Trace Elem Electrolytes Health Dis. 1993;7:205–210
  25. Navarro-Alarcon M, Cabrera-Vique C. Selenium in food and the human body: a review. Sci Total Environ. 2008;400:115–141
  26. Jitaru P, Prete M, Cozzi G, et al. Speciation analysis of selenoproteins in human serum by solid-phase extraction and affinity HPLC hyphenated to ICP-quadrupole MS. J Anal At Spectrom. 2008;23:402–406
  27. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32:13–61
  28. Huggett ASG, Nixon DA. Use of glucose oxidase, peroxidase, and o-dianisidine in determination of blood and urinary glucose. Lancet. 1957;270:368–370
  29. Jaynes PK, Willis MC, Chou PP. Evaluation of a mini-column chromatographic procedure for the measurement of hemoglobin A1c. Clin Biochem. 1985;18:32–36
  30. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–475
  31. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077–2080
  32. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem. 1990;27:297–312
  33. Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Clin Lab. 2000;46:53–55
  34. In:  Rao CR editors. Epidemiology and medical statistics. Atlanta, GA: Elsevier; 2008;
  35. Riffenburgh RH. Statistics in medicine. 2nd ed.. Burlington, MA: Academic Press; 2006;
  36. Bettmer J, Montes Bayón M, Ruiz Encinar J, Fernández Sánchez ML. Fernández de la Campa MdR, Sanz Medel A. The emerging role of ICP-MS in proteomic analysis. J Proteomics. 2009;72:989–1005
  37. Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007;9:775–806
  38. Rytter E, Vessby B, Asgard R, et al. Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects. Br J Nutr. 2009;101:1423–1426
  39. Douillet C, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M. Effect of selenium and vitamin E supplements on tissue lipids, peroxides, and fatty acid distribution in experimental diabetes. Lipids. 1998;33:393–399
  40. Natella F, Fidale M, Tubaro F, Ursini F, Scaccini C. Selenium supplementation prevents the increase in atherogenic electronegative LDL (LDL minus) in the postprandial phase. Nutr Metab Cardiovasc Dis. 2007;17:649–656
  41. Lloyd B, Lloyd RS, Clayton BE. Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J Epidemiol Community Health. 1983;37:213–217
  42. Persson-Moschos M, Alfthan G, Akesson B. Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium. Eur J Clin Nutr. 1998;52:363–367
  43. Allan CB, Lacourciere GM, Stadtman TC. Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr. 1999;19:1–16
  44. Francescato MP, Furlan G, Tamer I, Grand E, Bernard B. Selenium status in healthy Italian adults. J Hum Nutr Diet. 1991;4:219–222

PII: S1931-5244(10)00154-4

doi: 10.1016/j.trsl.2010.07.006

Translational Research
Volume 156, Issue 4 , Pages 242-250 , October 2010

Article Tools

* Image Usage & Resolution